๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Botulinum toxin A for drooling in Parkinson's disease: A pilot study to compare submandibular to parotid gland injections

โœ Scribed by Johanna G. Kalf; Anne M. Smit; Bastiaan R. Bloem; Machiel J. Zwarts; Wim M. Mulleners; Marten Munneke

Book ID
116820316
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
101 KB
Volume
13
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Botulinum toxin type A for drooling in P
Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study
โœ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla

The effect of injecting botulinum toxin
The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: A double blind placebo-controlled pilot study
โœ Tanya Gurevich; Chava Peretz; Orna Moore; Nina Weizmann; Nir Giladi ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB

## Abstract ## Objective To assess the effect on freezing of gait (FOG) of botulinum toxin type A (BTXโ€A) injections in advanced Parkinson's disease (PD) patients. ## Method BTXโ€A 150 IU or normal saline was injected into each leg's calf muscles by a blinded investigator. FOG severity was assess